BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38181731)

  • 1. omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases.
    Alvarado CX; Makarious MB; Weller CA; Vitale D; Koretsky MJ; Bandres-Ciga S; Iwaki H; Levine K; Singleton A; Faghri F; Nalls MA; Leonard HL
    Am J Hum Genet; 2024 Jan; 111(1):150-164. PubMed ID: 38181731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. omicSynth: an Open Multi-omic Community Resource for Identifying Druggable Targets across Neurodegenerative Diseases.
    Alvarado CX; Makarious MB; Weller CA; Vitale D; Koretsky MJ; Bandres-Ciga S; Iwaki H; Levine K; Singleton A; Faghri F; Nalls MA; Leonard HL
    medRxiv; 2023 Jul; ():. PubMed ID: 37090611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood.
    Ge YJ; Ou YN; Deng YT; Wu BS; Yang L; Zhang YR; Chen SD; Huang YY; Dong Q; Tan L; Yu JT;
    Biol Psychiatry; 2023 May; 93(9):770-779. PubMed ID: 36759259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
    Cheng JY; Deng YT; Yu JT
    J Neurochem; 2023 Sep; 166(6):972-981. PubMed ID: 37565992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
    Ning J; Huang SY; Chen SD; Zhang YR; Huang YY; Yu JT
    J Alzheimers Dis; 2022; 87(1):211-222. PubMed ID: 35275534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene discovery and validation for neurodegenerative diseases.
    Mathisen PM
    Drug Discov Today; 2003 Jan; 8(1):39-46. PubMed ID: 12546990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis.
    Jacobs BM; Taylor T; Awad A; Baker D; Giovanonni G; Noyce AJ; Dobson R
    Brain Commun; 2020; 2(2):fcaa119. PubMed ID: 33005893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
    Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic correlation and gene-based pleiotropy analysis for four major neurodegenerative diseases with summary statistics.
    Qiao J; Wang T; Shao Z; Zhu Y; Zhang M; Huang S; Zeng P
    Neurobiol Aging; 2023 Apr; 124():117-128. PubMed ID: 36740554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
    Baird DA; Liu JZ; Zheng J; Sieberts SK; Perumal T; Elsworth B; Richardson TG; Chen CY; Carrasquillo MM; Allen M; Reddy JS; De Jager PL; Ertekin-Taner N; Mangravite LM; Logsdon B; Estrada K; Haycock PC; Hemani G; Runz H; Smith GD; Gaunt TR;
    PLoS Genet; 2021 Jan; 17(1):e1009224. PubMed ID: 33417599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mendelian Randomization-Based Causal Investigation on Bacterial Infection-Related Genes and Neurodegenerative Diseases.
    Liu G; Lyu X; Wang V
    Stud Health Technol Inform; 2023 Nov; 308():619-632. PubMed ID: 38007792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study.
    Li C; Liu J; Lin J; Shang H
    Transl Psychiatry; 2022 Jul; 12(1):283. PubMed ID: 35835752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards unveiling the genetics of neurodegenerative diseases.
    Lill CM; Bertram L
    Semin Neurol; 2011 Nov; 31(5):531-41. PubMed ID: 22266890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteins and mutations: a new vision (molecular) of neurodegenerative diseases].
    Christen Y
    J Soc Biol; 2002; 196(1):85-94. PubMed ID: 12134639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function and neurodegenerative diseases : a two-sample Mendelian randomization study.
    Liu X; Ou YN; Ma YH; Huang LY; Zhang W; Tan L
    Neurol Res; 2023 May; 45(5):456-464. PubMed ID: 36692889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically Predicted Milk Intake and Risk of Neurodegenerative Diseases.
    Zhang Z; Wang M; Yuan S; Larsson SC; Liu X
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and its therapeutic implications in neurodegenerative diseases.
    Erekat NS
    Clin Anat; 2022 Jan; 35(1):65-78. PubMed ID: 34558138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel DNA methylation loci and genes showing pleiotropic association with Alzheimer's dementia: a network Mendelian randomization analysis.
    Liu D; Wang Y; Jing H; Meng Q; Yang J
    Epigenetics; 2022; 17(7):746-758. PubMed ID: 34461811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of microRNAs in neurodegeneration induced by environmental neurotoxicants and aging.
    Singh T; Yadav S
    Ageing Res Rev; 2020 Jul; 60():101068. PubMed ID: 32283224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Genetic Validation of the Neurodegeneration Biomarkers Tau-A and Tau-C - A Mendelian Randomization Study.
    Axelsen TM; Bager C; Bihlet A; Karsdal MA; Henriksen K; Tang MHE
    J Prev Alzheimers Dis; 2023; 10(3):536-542. PubMed ID: 37357295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.